Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Growth Metrics

Others

Odyssey Health (ODYY) Gains from Investment Securities (2020 - 2021)

Odyssey Health has reported Gains from Investment Securities over the past 2 years, most recently at $1.0 million for Q3 2021.

For Q3 2021, Gains from Investment Securities fell 93.02% year-over-year to $1.0 million; the TTM value through Jul 2021 reached $1.0 million, down 93.02%, while the annual FY2021 figure was $1.0 million, 93.02% down from the prior year.
Gains from Investment Securities for Q3 2021 was $1.0 million at Odyssey Health, down from $15.0 million in the prior quarter.
Over five years, Gains from Investment Securities peaked at $15.0 million in Q3 2020 and troughed at $50000.0 in Q1 2021.